CHF and arrhythmias:
Indications for: VYNDAQEL
Treatment in adults with cardiomyopathy of wild type or hereditary transthyretin-mediated amyloidosis (ATTR-CM) to reduce cardiovascular mortality and cardiovascular-related hospitalization.
Adult Dosage:
Swallow whole. 80mg once daily. Not substitutable with Vyndamax on a per mg basis.
Children Dosage:
Not established.
VYNDAQEL Warnings/Precautions:
Pregnancy. Advise females of reproductive potential to consider pregnancy planning and prevention. Nursing mothers: not recommended.
VYNDAQEL Classification:
Transthyretin (TTR) stabilizer.
VYNDAQEL Interactions:
May potentiate BCRP substrates (eg, methotrexate, rosuvastatin, imatinib).
Generic Drug Availability:
NO
How Supplied:
Caps—120
